Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report.
D000328:Adult; D003680:Deglutition Disorders / Q000209:etiology; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005881:Gingiva / Q000503:physiopathology; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008339:Mandibular Neoplasms / Q000188:drug therapy; D009055:Mouth; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*
D011033:Podophyllin